Despite the protective effects of SGK1 inhibition on atrial and ventricular fibrotic signaling, detailed echocardiographic assessment of systolic and diastolic function did not reveal any notable effects of obesity or SGK1 inhibition. The gene discussed is SGK1; the disease is obesity disorder.